LEXX 8-K 2026-09-09

Lexaria Bioscience Corp. (LEXX) 8-K dated 2026-09-09 — accession 0001640334-26-001468.

Lexaria Bioscience Corp. (LEXX) is a biotechnology company listed on US.

Lexaria Bioscience Corp. filed a 8-K on 2026-09-09. Accession 0001640334-26-001468.

This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LEXX revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXX currently screens at market cap $14.9M.

Not investment advice. The LEXX SEC hub lists recent forms. The stock page is the research view.